Skip to main content
  1. Life
  2. Pets
  3. Cats

Novartis Animal Health to get new owner

See also

Swiss drug maker Novartis announced April 22 that it plans to sell its animal health division to another pharmaceutical firm, Indianapolis-based Eli Lilly and Co., so it can focus on other business areas.

Lilly said the acquisition would complement its existing animal health unit, Elanco. Novartis cat products include Capstar flea treatment and Onsior pain medicine, while Elanco makes Comfortis flea tablets.

“Lilly will acquire Novartis Animal Health's nine manufacturing sites, six dedicated research and development facilities, a global commercial infrastructure with a portfolio of approximately 600 products, a robust pipeline with more than 40 projects in development, and an experienced team of more than 3,000 employees,” Lilly said. “Combining these two great companies will enable us to provide more diversified brands, reach more market segments, expand our global footprint, and strengthen our pipeline, capabilities and expertise.”

No changes to existing cat products are planned, said Elanco spokeswoman Colleen Parr Dekker.

If approved by regulators, the $5.4 billion deal is expected to take effect by the first quarter of 2015.

SUBSCRIBE! To receive future cat articles by this writer, click “Subscribe” above. Follow him on Facebook and Twitter.



  • ESPYS party
    Athletes and celebrities hit the red carpet at Body at the ESPYS party
    Today's Buzz
  • Healthy balance
    Keeping a healthy balance is so important for your own well-being
    15 Photos
  • Apollo
    NASA observes 45th anniversary of Apollo 11: One giant leap for mankind
    14 Photos
  • Unique jewelry
    Nothing catches the eye or completes and outfit like a great piece of jewelry
    12 Photos
  • Student Farmworker Alliance
    Student-Farmworker Alliance launches 'Boot the Braids' web site
    15 Photos
  • Exercise
    Find out why you should exercise to compliment your diet
    10 Photos